Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
IPO Year: 2016
Exchange: NASDAQ
Website: tactilemedical.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/6/2025 | $14.00 | Overweight → Neutral | Piper Sandler |
| 2/19/2025 | $23.00 → $18.00 | Buy → Neutral | B. Riley Securities |
| 11/5/2024 | Outperform → Perform | Oppenheimer | |
| 11/5/2024 | Buy → Neutral | BTIG Research | |
| 9/26/2024 | $23.00 | Buy | B. Riley Securities |